Education
About Us
Working with TipRanks
Follow Us
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -3.66M | $ -3.40M | $ -658.00K | $ -325.00K | $ -1.06M |
| EBITDA | $ 318.00K | $ 378.84K | $ -74.00 | $ -325.00K | $ -1.06M |
| Net Income | $ -3.34M | $ -3.03M | $ 12.11M | $ -299.00K | $ -1.06M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.61M | $ 8.84M | $ 11.95M | $ 30.63K | $ 75.06K |
| Total Assets | $ 5.69M | $ 8.95M | $ 11.98M | $ 58.78K | $ 131.76K |
| Total Debt | $ 0.00 | $ 0.00 | $ 411.00K | $ 231.00K | $ 96.60K |
| Net Debt | $ -5.61M | $ -8.84M | $ -11.54M | $ 200.37K | $ 21.54K |
| Total Liabilities | $ 3.71M | $ 3.67M | $ 3.68M | $ 3.68M | $ 3.49M |
| Stockholders' Equity | $ 1.99M | $ 5.28M | $ 8.30M | $ -3.62M | $ -3.36M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.23M | $ -2.70M | $ 11.74M | $ -220.43K | $ -825.36K |
| Operating Cash Flow | $ -3.23M | $ -2.70M | $ 11.74M | $ -220.43K | $ -825.36K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ -411.00K | $ 180.00K | $ 176.00K | $ 96.60K |
Inhibitor Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.